hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine

A cancer vaccine containing autologous dendritic cells (DCs) that are pulsed with mRNA encoding human telomerase reverse transcriptase (hTERT) and survivin peptide, with potential immunostimulatory and antineoplastic activities. Upon administration, hTERT mRNA/survivin peptide-double-loaded autologous dendritic cell vaccine may elicit an immune response against cancer cells expressing hTERT and survivin by activating cytotoxic T-cells (CTLs), natural killer cells (NKs), and B-lymphocytes. The tumor associated antigens (TAAs) hTERT, the catalytic subunit of human telomerase, and survivin, a member of the inhibitor of apoptosis (IAP) family of proteins, may be upregulated in certain tumor cell types and play key roles in tumor cell growth and survival. (NCI Thesaurus)

YOU MAY ALSO LIKE

hTERT I540/R572Y/D988Y Multipeptide Vaccine

A peptide vaccine consisting of multiple epitopes derived from the human telomerase reverse transcriptase (hTERT), the catalytic subunit of human telomerase, with…

HTC2 Gene

Human HTC2 gene is located within Xq24-q27.1 and the size of this phenotypic locus is not reported. This gene region has no…

HTATIP2 wt Allele

Human HTATIP2 wild-type allele is located in the 11p15.1 and is approximately 20 kb in length. This allele, which encodes oxidoreductase HTATIP2…

HTATIP2 Gene

This gene is involved in the regulation of apoptosis and induces cell death.

HT-Zip Domain

Bipartite DNA binding domain containing a helix-turn and a leucine zipper.

HT-29

Human colonic adenocarcinoma cells that are able to express differentiation features characteristic of mature intestinal cells. These cells have mainly been used…